These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24594679)

  • 1. Hepatitis C virus screening in patients with cancer receiving chemotherapy.
    Hwang JP; Suarez-Almazor ME; Torres HA; Palla SL; Huang DS; Fisch MJ; Lok AS
    J Oncol Pract; 2014 May; 10(3):e167-74. PubMed ID: 24594679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low rates of hepatitis B virus screening at the onset of chemotherapy.
    Hwang JP; Fisch MJ; Zhang H; Kallen MA; Routbort MJ; Lal LS; Vierling JM; Suarez-Almazor ME
    J Oncol Pract; 2012 Jul; 8(4):e32-9. PubMed ID: 23180996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.
    Méndez-Navarro J; Corey KE; Zheng H; Barlow LL; Jang JY; Lin W; Zhao H; Shao RX; McAfee SL; Chung RT
    Liver Int; 2011 Mar; 31(3):330-9. PubMed ID: 20738779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for viral hepatitis prior to rituximab chemotherapy.
    Leonard AN; Love BL; Norris LB; Siddiqui SK; Wallam MN; Bennett CL
    Ann Hematol; 2016 Jan; 95(1):27-33. PubMed ID: 26382277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma.
    Guarino M; Picardi M; Vitello A; Pugliese N; Rea M; Cossiga V; Pane F; Caporaso N; Morisco F
    Ann Hepatol; 2017; 16(2):198-206. PubMed ID: 28233742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study.
    Torres HA; Hosry J; Mahale P; Economides MP; Jiang Y; Lok AS
    Hepatology; 2018 Jan; 67(1):36-47. PubMed ID: 28653760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
    Su YC; Lin PC; Yu HC; Wu CC
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.
    Liu CY; Chandrasekar PH; Masood A; Schiffer CA
    J Oncol Pharm Pract; 2013 Mar; 19(1):18-23. PubMed ID: 22635416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience.
    Oh MJ; Lee HJ
    Clin Mol Hepatol; 2013 Mar; 19(1):51-9. PubMed ID: 23593610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hepatitis C virus infection on the safety of chemotherapy for breast cancer patients.
    Liu Y; Li ZY; Wang JN; Li X; Huang QA; Huang Y
    Breast Cancer Res Treat; 2017 Jul; 164(2):379-383. PubMed ID: 28447238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C screening trends in a large integrated health system.
    Linas BP; Hu H; Barter DM; Horberg M
    Am J Med; 2014 May; 127(5):398-405. PubMed ID: 24486288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 - 1965.
    Cartwright EJ; Rentsch C; Rimland D
    BMC Res Notes; 2014 Jul; 7():449. PubMed ID: 25023159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.
    Yazici O; Sendur MA; Aksoy S
    World J Gastroenterol; 2014 Jun; 20(22):6716-24. PubMed ID: 24944464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
    Nosotti L; D'Andrea M; Pitidis A; Pimpinelli F; Dessanti ML; Pisani F; Vignally P; Petti MC
    Scand J Infect Dis; 2012 Jan; 44(1):70-3. PubMed ID: 21905952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
    Talima S; Kassem H; Kassem N
    Breast Cancer; 2019 Mar; 26(2):154-163. PubMed ID: 30191397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience.
    Nishikawa H; Tsudo M; Osaki Y
    Oncol Rep; 2012 Sep; 28(3):835-40. PubMed ID: 22736295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients.
    Mahale P; Kontoyiannis DP; Chemaly RF; Jiang Y; Hwang JP; Davila M; Torres HA
    J Hepatol; 2012 Dec; 57(6):1177-85. PubMed ID: 22871500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus screening of high-risk patients in a community hospital emergency department: Retrospective review of patient characteristics and future implications.
    Park JS; Wong J; Cohen H
    PLoS One; 2021; 16(6):e0252976. PubMed ID: 34111200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver toxicity of chemotherapy and targeted therapy for breast cancer patients with hepatitis virus infection.
    Liu Y; Li ZY; Li X; Wang JN; Huang QA; Huang Y
    Breast; 2017 Oct; 35():191-195. PubMed ID: 28800545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.